NUTRACHAMPION PODCAST: EPISODE 7

LISTEN: ‘Great promise’ - Prof Luis Vitetta on CBD hopes, probiotics research and migration experience

By Tingmin Koe contact

- Last updated on GMT

Related tags: Cbd, Probiotics, Australia

Cannabidiol (CBD) and tetrahydrocannabinol (THC) are increasingly gaining traction and are said to hold “great promise” for managing chronic pain, claims a leading Australian researcher who stars in our seventh NutraChampion podcast.
Professor Luis Vitetta
Professor Luis Vitetta

Professor Luis Vitetta, the director of Medical Research at MedLab, a biotech firm based in Australia, has been leading the firm’s research on medical cannabis, microbiome, probiotics for the past seven-and-a-half years.

The firm’s research funds are generated from its sales of nutraceuticals.  The eventual goal is to develop pharmaceutical grade medicines, such as medical cannabis.

Prof Vitteta said that the firm’s medical cannabis formulation, known as NanaBis, was shown to be safe and tolerable in a pilot study result.

“It is about to go through a phase 3 clinical trial with three centres in Australia and one in the US, because it will go through the FDA fixed-drug combination pathway.

“As such, it has great promise in managing cancer pain in patients who like to have alternative to opioids,” ​he told NutraIngredients-Asia.

The firm also recently completed a clinical trial on the use of a probiotic and magnesium orotate formulation, the NRGBiotic, for managing depression.

Prior to joining the industry, Professor Vitetta was the director and associate professor of the Centre for Integrative Clinical and Molecular Medicine at The University of Queensland, School of Medicine.

Born in Argentina, his parents brought him to Australia 57 years ago in pursuit of a brighter future, a move which he greatly thanked his parents for.

Listen to find out more about his life and career.

 

 

Related news

Show more

Related products

show more

Immune response, Healthy aging and inflammation

Immune response, Healthy aging and inflammation

FITOPLANCTON MARINO | 14-Jul-2020 | Technical / White Paper

Reactive oxygen species (ROS) are produced as a consequence of metabolic processes. When antioxidant capabilities are overwhelmed by the burden of ROS...

DHA ORIGINS™: The sustainable potential of algae.

DHA ORIGINS™: The sustainable potential of algae.

Fermentalg | 29-Jun-2020 | Technical / White Paper

Consumers find out about nutritional quality by closely scrutinizing the labeling and list of ingredients (clean label). They are interested in the provenance...

HRB probiotics: The gift of life for infant health

HRB probiotics: The gift of life for infant health

Morinaga Milk Industry Co., Ltd. | 29-Jun-2020 | Technical / White Paper

Bifidobacteria are among the first colonizers of human gut, and certain species are recognised as Human-Residential Bifidobacteria (HRB) - the natural...

Related suppliers

Follow us

Products

View more

Webinars

Nutra Champions Podcast

Nutra Champions Podcast